Extrafine single inhaler triple therapy is effective among patients with COPD who were previously treated with multiple-inhaler triple therapy.

The US Food and Drug Administration has approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic ...

The CHEST Annual Meeting 2024 will take place in Boston, Massachusetts, from October 6 to 9, where experts will discuss ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy has been approved in Malaysia for respiratory ...

Accelerating the decline in tobacco smoking globally, by decreasing smoking prevalence from current levels to 5% everywhere, ...

HealthDay News — Conditions offering alternative explanations for lung cancer symptoms are associated with increased diagnostic intervals, according to a study published online Aug. 23 in the British ...

A 3D reconstruction of a mouse lung four days after infection with fluorescent Sendai virus reveals widespread virus presence (red) and active replication (green).

Researchers found that respiratory viruses like RSV can persist in lung immune cells long after initial infection, creating ...

With each breath, a human may inhale thousands of harmful microbes into the lungs. Mucus, the gel-like moist substance coating the airways, is one of the first lines of defense and aids in removal ...

The 2024 AARC Zenith Award recognizes outstanding contributions in the respiratory care profession. Monaghan was recognized by AARC members for their exceptional products, accessible sales staff, ...

A study predicts significant health benefits if smoking is eliminated globally by 2050. Reducing smoking rates to 5% by 2050 ...

Immediately linking chronic obstructive pulmonary disease (COPD) and asthma patients who smoke to an appointment at a smoking cessation clinic significantly improved quit rates, a multicenter trial ...